Difficult diagnosis and localization of focal nesidioblastosis: clinical implications of ⁶⁸Gallium-DOTA-D-Phe¹-Tyr³-octreotide PET scanning
Annals of Surgical Treatment and Research
; : 51-55, 2016.
Article
de En
| WPRIM
| ID: wpr-135117
Bibliothèque responsable:
WPRO
ABSTRACT
Focal nesidioblastosis is a rare cause of endogenous hyperinsulinemic hypoglycemia in adults. Because it is difficult to localize and detect with current imaging modalities, nesidioblastosis is challenging for biliary-pancreatic surgeons. ⁶⁸Gallium-DOTA-D-Phe¹-Tyr³-octreotide PET scanning and ¹¹¹indium-pentetreotide diethylene triamine pentaacetic acid octreotide scanning may be superior to conventional imaging modalities in determining the localization of nesidioblastosis. We report the successful surgical treatment of a 54-year-old woman with focal hyperplasia of the islets of Langerhans, who experienced frequent hypoglycemic symptoms and underwent various diagnostic examinations with different results.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Octréotide
/
Ilots pancréatiques
/
Nésidioblastose
/
Tomographie par émission de positons
/
Diagnostic
/
Chirurgiens
/
Hyperplasie
/
Hypoglycémie
Type d'étude:
Diagnostic_studies
Limites du sujet:
Adult
/
Female
/
Humans
langue:
En
Texte intégral:
Annals of Surgical Treatment and Research
Année:
2016
Type:
Article